TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis-Reference-Cited by-全球学者库

TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis

Published:2020-03-04 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Zhang Liping¹,Zhang Bingqian¹,Wei Muyun²,Xu Zhen¹,Kong Weiya¹,Deng Ke¹,Xu Xinxin³,Zhang Lin⁴,Ζhao Xingbo²,Yan Lei¹

Affiliation:

1. School of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China

2. Department of Obstetrics and Gynecology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China

3. Center for Reproductive Medicine, Reproductive Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China

4. Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan, Shandong 250001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8;mBio;2024-01-26

2. Integrating RNA-sequencing and network analysis to explore the mechanism of topical Pien Tze Huang treatment on diabetic wounds;Frontiers in Pharmacology;2024-01-16

3. A novel predictive model based on inflammatory response-related genes for predicting endometrial cancer prognosis and its experimental validation;Aging;2023-06-05

4. miR-548c-3p targets TRIM22 to attenuate the Peg–IFN–α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B;Antiviral Research;2023-05

5. Cinobufacini suppresses malignant behaviors of endometrial cancer by regulating NF-κB pathway;Biotechnology and Genetic Engineering Reviews;2023-04-06